Northern Mariana Islands Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Northern Mariana Islands Health News.

Press releases published on July 14, 2026

Jul. 14, 2026

MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia

Indeterminate GlobeNewswire

Jul. 14, 2026

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

Indeterminate GlobeNewswire

Jul. 14, 2026

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 14, 2026

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

Indeterminate GlobeNewswire

Jul. 14, 2026

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

Indeterminate GlobeNewswire

Jul. 14, 2026

Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China

Indeterminate GlobeNewswire

Jul. 14, 2026

Smile Doctors Outpaces First-Half Growth Plan, Nears 600 Locations Nationwide

Indeterminate GlobeNewswire

Jul. 14, 2026

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

Indeterminate GlobeNewswire

Jul. 14, 2026

Home Instead Named to TIME America’s Best Private Companies 2026 List

Indeterminate GlobeNewswire

Jul. 14, 2026

FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer

Indeterminate GlobeNewswire

Jul. 14, 2026

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

Indeterminate GlobeNewswire

Jul. 14, 2026

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

Indeterminate GlobeNewswire

Jul. 14, 2026

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Indeterminate GlobeNewswire

Jul. 14, 2026

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding 

Indeterminate GlobeNewswire

Jul. 14, 2026

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Indeterminate GlobeNewswire

Jul. 14, 2026

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

Indeterminate GlobeNewswire

Jul. 14, 2026

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire

Jul. 14, 2026

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Indeterminate GlobeNewswire

Jul. 14, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Jul. 14, 2026

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Indeterminate GlobeNewswire